Related Experiment Video
Updated: Dec 31, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Spotlight on comorbidities in STEMI patients
Raphael Romano Bruno1, Malte Kelm1, Christian Jung1
1Division of Cardiology, Pulmonology, and Vascular Medicine Medical Faculty University Hospital Düsseldorf Dusseldorf Germany.
Insights
Mortality from myocardial infarction is decreasing. However, comorbidities like hyperglycemia increase risks. Continuous insulin infusion therapy in STEMI patients unexpectedly raised mortality risks significantly.
Area of Science:
- Cardiology
- Endocrinology
- Critical Care Medicine
Background:
- Myocardial infarction (MI) mortality is at a 20-year low.
- Comorbidities like anemia, renal failure, and hyperglycemia are emerging as critical risk modifiers in acute MI.
- Stress hyperglycemia is common in ST-elevation myocardial infarction (STEMI).
Discussion:
- Continuous insulin infusion therapy (CIIT) in STEMI patients was investigated for its impact on mortality.
- The study examined in-hospital and 1-year mortality rates associated with CIIT in STEMI.
Key Insights:
- CIIT was associated with a >threefold increase in in-hospital mortality.
- CIIT showed a >twofold increase in 1-year mortality for STEMI patients.
- These findings highlight a potential adverse effect of CIIT in this patient population.
Outlook:
- Further research is needed to understand the mechanisms behind CIIT's adverse effects in STEMI.
- Investigating alternative glycemic control strategies for STEMI patients with stress hyperglycemia is crucial.
- Identifying safer interventions for managing comorbidities in acute MI is a priority.
Abstract:
Mortality for myocardial infarction is at its lowest historical level for 20 years, but comorbidities such as anemia, renal failure and hyperglycemia seem the next frontier to investigate their impact as risk modifiers mortality in acute myocardial infarction. Stress hyperglycemia is a very frequent problem in STEMI, but continuous insulin infusion therapy (CIIT) resulted in >threefold and >twofold increased risks in-hospital and 1-year mortality, respectively.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care